Question 1

What is the catalog number for Methyl 5-bromo-2-fluoro-3-sulfamoylbenzoate?

Accepted Answer

The catalog number for Methyl 5-bromo-2-fluoro-3-sulfamoylbenzoate is SDC74016.

Question 2

What sizes are available for Methyl 5-bromo-2-fluoro-3-sulfamoylbenzoate?

Accepted Answer

Methyl 5-bromo-2-fluoro-3-sulfamoylbenzoate is available in the following size(s): 50 mg, 0.5 g.

Question 3

How many pack sizes does Methyl 5-bromo-2-fluoro-3-sulfamoylbenzoate come in?

Accepted Answer

Methyl 5-bromo-2-fluoro-3-sulfamoylbenzoate is available in 2 different pack sizes.

Question 4

Is Methyl 5-bromo-2-fluoro-3-sulfamoylbenzoate in stock?

Accepted Answer

Methyl 5-bromo-2-fluoro-3-sulfamoylbenzoate is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What buffer is this product supplied in?

Accepted Answer

The formulation or storage buffer is listed on the product datasheet. If you require a carrier-free or custom formulation, contact us before ordering, as this may involve a made-to-order production timeline.

Question 6

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

Accepted Answer

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.

Question 7

Can I request a Safety Data Sheet (SDS) for this product?

Accepted Answer

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

Methyl 5-bromo-2-fluoro-3-sulfamoylbenzoate

Product Specifications

CAS Number

MDL Number

Smiles

Molecular Formula

Molecular Weight

Controlled

Available Sizes

Frequently Asked Questions

Explore Other Products

IL3RB (CSF2RB) Rabbit Polyclonal Antibody

APC Anti-Mouse CD80 Antibody[16-10A1]

APC Anti-Mouse CD80 Antibody[16-10A1]

OR1L8 (NM_001004454) Human Over-expression Lysate

Recombinant Human CSRP1 Protein (His Tag)

NTAL (LAT2) Human Gene Knockout Kit (CRISPR)